Given that loss of stromal BMPR2 expression increases cytokine production in a mouse model of breast cancer,28 further studies are warranted to investigate whether mesenchymal BMP signaling, modulated by GREM1 and ISLR, could also be involved in shaping the immunosuppressive tumor microenvironment. This evidence concerns the gene BMPR2 and breast carcinoma.